Overview of the multifaceted resistances toward EGFR-TKIs and new chemotherapeutic strategies in non-small cell lung cancer
The role of epidermal growth factor receptor (EGFR) in non-small cell lung cancer (NSCLC) has been vastly studied over the last decade. This has led to the rapid development of many generations of EGFR tyrosine kinase inhibitors (EGFR-TKIs). However, patients treated with third-generation TKIs (osim...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Published: |
Elsevier
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/40814/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|